Abstract
Speakers: John Ashby (Syngenta CTL, UK), Peter A.Behnisch (Eurofins GfA, Germany), Paul L.Carmichael (Unilever Colworth, UK), Curtis C.Harris (National Cancer Institute, USA), Kevin C.Jones (Lancaster University, UK), Andreas Kortenkamp (School of Pharmacy, London, UK), Caroline J.Langdon (Reading University, UK), Anthony M.Lynch (GlaxoSmithKline, UK), Francis L.Martin (Lancaster University, UK), Trevor J.McMillan (Lancaster University, UK), David H.Phillips (Institute of Cancer Research, UK), Huw J.Ricketts (University of Cardiff, UK), Michael N.Routledge (University of Leeds, UK), J.Thomas Sanderson (Utrecht University, The Netherlands) and Kirk T.Semple (Lancaster University, UK)